A new study from the Perelman School of Medicine at the University of Pennsylvania shows that antibody responses to new SARS-CoV-2 variant infections and vaccinations are powerfully shaped by prior exposures to earlier SARS-CoV-2 vaccines.
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants, study finds
